Autism R&D Pipeline Analysis Report, H2-2018 Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
26
Autism R&D Pipeline Analysis Report, H2-2018 Therapeutics Review

Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Autism R&D Pipeline Analysis Report, H2-2018" report has been added to ResearchAndMarkets.com's offering. The Autism pipeline guide presents complete overview of drugs currently being developed for Autism. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Autism pipeline candidate. Research and Development progress along with latest news related to each of the Autism pipeline candidates is included. Major companies participating in therapeutic development of Autism are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided. Amid strong interest for cure of Autism from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Autism clinical and pre clinical products. The report assists in identifying potential upcoming companies and drugs in Autism pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition. Key Topics Covered: I. Key Findings 1. Companies Investing in Autism Pipeline include Number of Companies with Autism projects in pre clinical Development Number of Companies with Autism projects in Clinical Development Autism Pipeline Companies based in Americas Autism Pipeline Companies based in Europe Autism Pipeline Companies based in Asia Pacific Autism Pipeline Companies based in Rest of the World 2. Pipeline Candidates include Autism Pipeline Agents in pre clinical/ Discovery stage of Development Autism Pipeline Agents in Clinical Development stage Autism Pipeline Therapeutic Compounds received special status Mechanism of Action of most pipeline Drugs Small molecules among the Autism Pipeline agents II. Insights into Autism Pipeline - 1. Disease Overview Introduction to Autism Symptoms and Causes of Autism Treatment or Prevention Options for Autism Other Details 2. Phase wise Pipeline Compounds Autism Pipeline Pre Clinical/ Discovery stage Drugs Autism Pipeline Phase 1 stage Drugs Autism Pipeline Phase 2 stage Drugs Autism Pipeline Phase 3 stage Drugs Autism Pipeline Pre Registration stage Drugs 3. Company wise Autism Pipeline Compounds 4. Autism Pipeline by Mechanism of Action III. Autism Pipeline Compound Details Drug Details 1. Snapshot Name of the Therapeutic Agent Originator Developing Company Co Developer/ License Partner Orphan Drug / Fast Track/ Designation Development Phase 2. Drug Overview 3. Mechanism of Action 4. Current Status 5. Clinical Trial Details IV. Autism Pipeline Company Briefs V. Latest News and Developments in Global Autism Pipeline Market VI. Appendix For more information about this report visit https://www.researchandmarkets.com/research/9...randd?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Central Nervous System Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lazard's October 2026 AUM: Navigating Market Swings

Updated Category News Views 49

October AUM: Ups and Downs for Lazard God, if there's one constant in the world of investment, it's that nothing stays the same—and Lazard's latest asset under management (AUM) report proves it. Released with all the flair of a late-night diner special, the report shows Lazard's AUM came in at $282.4 billion as of October 31, 2026. Not earth-shattering at first glance,...

Continue Reading
El Niño 2026: Agricultural Strains Demand Swift Action

Updated Category News Views 50

El Niño Strikes Again: Farmers Brace for Impact Folks in agriculture are feeling the heat—literally. It's 2026 and the infamous El Niño has cranked up the pressure dial on farmers across Asia-Pacific, Africa, and South America. Drought conditions running rampant, crops gasping for a drink, the scene's not pretty. Some are already calling this one of the worst El...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
VIAVI Innovates with 5G Digital Twins in UK Transport

Updated Category News Views 20

VIAVI Rides the Rails with Digital Twins The latest buzzword flashing across the tech scene? Digital twins. But VIAVI Solutions Inc. (NASDAQ: VIAV) isn’t just riding the trend; it's driving it forward. Partnering up with ORBIT, this heavy-hitter aims to redesign the digital blueprint of Blackpool's transportation system. And no, this ain't just pretty talk for...

Continue Reading
Global Museum of Illusions Comes to San Francisco

Updated Category News Views 216

Illusions on Market Street The Global Museum of Illusions, the fast-growing sensation in private museums, is setting its sights on San Francisco with a new location opening on Market Street this November 13. They're dangling a juicy 50% off presale ticket offer for the early birds. A Mind-Bending Experience This museum isn't your run-of-the-mill art gallery or historical...

Continue Reading
Specialty1 Partners: Top Workplaces Triumph in 2026

Updated Category News Views 167

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...

Continue Reading
Pomifera's Holiday Skincare Sets: A Gift of Glow

Updated Category News Views 56

Unwrapping Pomifera's Holiday Magic When it comes to holiday gifts, nothing says 'I care' like a touch of skincare magic, and Pomifera's got your back. The brand, known for its signature Pomifera Oil, is turning the art of gifting into an indulgence with three curated collections. These ain't your run-of-the-mill lotions and potions. We're talking about products that...

Continue Reading
Fort Riley and Fort Wainwright Get Wi-Fi Boost

Updated Category News Views 216

Reliable Connectivity for Soldiers: A Strategic Move Wi-Fi probably wouldn't be on top of the list in a battlefield strategy session, but give it a thought—it’s the digital lifeline for our troops off-duty. That’s what’s cooking with the U.S. Army’s big move to amp up reliable Wi-Fi at Fort Riley and Fort Wainwright, thanks to Boldyn Networks and their BaseNet...

Continue Reading
Interfuse Unveils Niesen.com: A New Digital Hub

Updated Category News Views 34

Diving into Digital Heritage There’s something brewing in Madison, Wisconsin—a concoction of tech, history, and a dash of creative oomph. Interfuse, the tech-savvy brains behind digital platforms and publishing wonders, has rolled out Niesen.com. It’s like a virtual playground for anyone with a link to, or curiosity about, the Niesen name. But this isn’t just some...

Continue Reading
Next Bridge Hydrocarbons' Call for Presidential Intervention

Updated Category News Views 59

Trump's New Team: A Hope for Shareholder Relief? Picture the scene—Next Bridge Hydrocarbons, caught in the depths of shareholder unrest over the unresolved MMTLP fiasco, is looking to the top for answers. With a fresh face, Stephen Miller, stepping in as the White House Chief of Staff, there's a new angle at play. They're knocking on the doors of the Trump...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growing Gap Between Silver's Price and Reality

Updated Category News Views 210

Understanding the Current Silver Market Dynamics Silver has emerged as a key asset over the past year, showcasing a remarkable rise, positioning itself as a prime investment in modern markets. Unlike the speculative spikes seen in previous decades, today's surge doesn't mirror past patterns, such as those seen during the Hunt brothers' famous investments or the reactions...

Continue Reading
Top Gold Stocks to Consider as Prices Continue to Surge

Updated Category News Views 359

Gold Prices Reach New Heights The price of gold has recently exhibited a remarkable upward trend, reaching all-time highs. Investors are excited as gold prices surged close to $2,800 per ounce, reflecting a significant return that soared over 30% in the previous year. This price movement indicates a favorable environment for those considering investment opportunities in...

Continue Reading
Chris Hoal Takes Lead as Gresham Smith's Design Director

Updated Category News Views 151

Chris Hoal Appointed as Director of Architectural Design Gresham Smith, a leading firm in architecture, engineering, and consultancy services, is thrilled to announce Chris Hoal as the new Director of Architectural Design. Hoal, who has been a pivotal figure at the company since 2012, will venture into this role to further enhance the firm's commitment to delivering...

Continue Reading
Analysis of DexCom's Recent Challenges and Stock Decline

Updated Category News Views 179

Understanding DexCom's Recent Performance Challenges DexCom, Inc. (DXCM) is navigating a difficult period after seeing its stock plummet by 40%. This dramatic decline is tied to disappointing financial results, particularly highlighted in the company's concerning Q2 earnings report, which showed a stark difference between actual sales figures and what analysts had...

Continue Reading
Legal Investigation on Behalf of Investors of Atkore Inc.

Updated Category News Views 124

Legal Investigation on Behalf of Investors of Atkore Inc. Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential claims on behalf of investors who may have suffered losses exceeding $50,000 in Atkore, Inc. (NYSE: ATKR). Investors are urged to reach out to the firm to explore their legal options regarding these financial investments....

Continue Reading